DOI:
10.1055/s-00000182
Journal of Neurological Surgery Reports
LinksClose Window
References
Joshua AM, Ezzat S, Asa SL , et al.
Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma.
J Clin Endocrinol Metab 2009;
94 (1) 5-9
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.